Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol TCI for recovery after gynecologic laparoscopic cancer surgery
ChiCTR2300068713Phase 4Not yet recruiting
- Sponsor
- Foshan Maternity & Child Healthcare Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Gynecological neoplasia (2 arms), sponsored by Foshan Maternity & Child Healthcare Hospital. Primary endpoint: QoR-15 score. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Gynecological neoplasia
Beyond the preview
Go deeper on ChiCTR2300068713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068713.